Kutikov Alexander, Guzzo Thomas J, Malkowicz S Bruce
Division of Urology, Department of Surgery, University of Pennsylvania Medical Center, 9 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Radiol Clin North Am. 2006 Sep;44(5):649-63, vii. doi: 10.1016/j.rcl.2006.07.003.
Prostatic disease continues to present clinicians with challenges. Although giant strides have been made in the medical and surgical management of benign prostatic hyperplasia, many fundamental questions about its pathogenesis, progression, and treatment efficacy remain unanswered. Prostate cancer also continues to be an area in which progress is needed despite major recent advancements. Numerous debates that include the value of prostate-specific antigen screening and appropriate roles for each of the numerous therapeutic modalities await resolution. For millions of patients who suffer from prostatitis, a major breakthrough is yet to come. Current treatment regimens for prostatitis remain ineffective at best. Contemporary approaches to the pathogenesis, diagnosis, and treatment of benign prostatic hyperplasia, prostate cancer, and prostatitis are discussed in this review.
前列腺疾病仍然给临床医生带来挑战。尽管在良性前列腺增生的药物和手术治疗方面已经取得了巨大进展，但关于其发病机制、进展和治疗效果的许多基本问题仍未得到解答。尽管最近取得了重大进展，但前列腺癌仍然是一个需要取得进展的领域。包括前列腺特异性抗原筛查的价值以及众多治疗方式各自的适当作用等众多争论有待解决。对于数百万患有前列腺炎的患者来说，重大突破尚未到来。目前前列腺炎的治疗方案充其量仍然无效。本综述讨论了良性前列腺增生、前列腺癌和前列腺炎的发病机制、诊断和治疗的当代方法。
